• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类溶酶体酸性脂肪酶中的L273S错义替换产生了一个新的N-糖基化位点。

L273S missense substitution in human lysosomal acid lipase creates a new N-glycosylation site.

作者信息

Pariyarath R, Pagani F, Stuani C, Garcia R, Baralle F E

机构信息

International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.

出版信息

FEBS Lett. 1996 Nov 11;397(1):79-82. doi: 10.1016/s0014-5793(96)01134-9.

DOI:10.1016/s0014-5793(96)01134-9
PMID:8941718
Abstract

Human lysosomal acid lipase (LAL), when expressed in HeLa cells using the Vaccinia T7 expression system, showed four major molecular forms ranging from 42 to 54 kDa. Treatment with endoglycosidase H resulted in a 42 kDa protein, indicating that the molecular weight variations were due to N-glycosylation. A missense substitution, L273S, previously detected in a patient with cholesteryl ester storage disease (CESD), produced catalytically inactive LAL showing a largest molecular mass form of 56 kDa instead of 54 kDa. Analysis of the amino acid sequence in the close proximity of the mutation (NMS- NML) indicated that the L273S mutation creates an additional N-glycosylation consensus (N-X-S/T) in this region. Two site directed mutants disrupting this consensus, QMS and QML, when expressed in HeLa cells, did not show the 56 kDa form but the normal 54 kDa band whereas deglycosylation always resulted in the major 42 kDa form, as observed with normal LAL and the L273S mutant. These data confirmed that an additional N-glycosylation at N271 was responsible for the 56 kDa form of the protein produced from the L273S allele. Furthermore, deglycosylation of normal LAL reduced the acid hydrolase activity towards both tri-oleyl glycerol and cholesteryl oleate by 50%, strongly suggesting that N-linked carbohydrate residues are important for optimal catalytic activity.

摘要

当使用痘苗T7表达系统在HeLa细胞中表达时,人溶酶体酸性脂肪酶(LAL)显示出四种主要分子形式,分子量范围为42至54 kDa。用内切糖苷酶H处理后产生了一种42 kDa的蛋白质,这表明分子量的变化是由于N-糖基化所致。先前在一名患有胆固醇酯贮积病(CESD)的患者中检测到的错义替代L273S,产生了催化无活性的LAL,其最大分子量形式为56 kDa,而不是54 kDa。对突变附近(NMS-NML)的氨基酸序列分析表明,L273S突变在该区域产生了一个额外的N-糖基化共有序列(N-X-S/T)。在HeLa细胞中表达时,破坏该共有序列的两个定点突变体QMS和QML没有显示出56 kDa的形式,而是正常的54 kDa条带,而去糖基化总是产生主要的42 kDa形式,这与正常LAL和L273S突变体的情况相同。这些数据证实,N271处额外的N-糖基化是由L273S等位基因产生的56 kDa形式蛋白质的原因。此外,正常LAL的去糖基化使对三油酰甘油和胆固醇油酸酯的酸性水解酶活性降低了50%,这强烈表明N-连接的碳水化合物残基对于最佳催化活性很重要。

相似文献

1
L273S missense substitution in human lysosomal acid lipase creates a new N-glycosylation site.人类溶酶体酸性脂肪酶中的L273S错义替换产生了一个新的N-糖基化位点。
FEBS Lett. 1996 Nov 11;397(1):79-82. doi: 10.1016/s0014-5793(96)01134-9.
2
Expression of lysosomal acid lipase mutants detected in three patients with cholesteryl ester storage disease.在三名胆固醇酯贮积病患者中检测到的溶酶体酸性脂肪酶突变体的表达。
Hum Mol Genet. 1996 Oct;5(10):1611-7. doi: 10.1093/hmg/5.10.1611.
3
Purification, characterization and molecular cloning of human hepatic lysosomal acid lipase.人肝脏溶酶体酸性脂肪酶的纯化、特性鉴定及分子克隆
Eur J Biochem. 1994 Feb 1;219(3):905-14. doi: 10.1111/j.1432-1033.1994.tb18572.x.
4
Expression and functional characterization of human lysosomal acid lipase gene (LIPA) mutation responsible for cholesteryl ester storage disease (CESD) phenotype.导致胆固醇酯贮积病(CESD)表型的人类溶酶体酸性脂肪酶基因(LIPA)突变的表达及功能特性
Protein Expr Purif. 2015 Jun;110:22-9. doi: 10.1016/j.pep.2014.12.009. Epub 2015 Jan 22.
5
Difference in substrate specificity between human and mouse lysosomal acid lipase: low affinity for cholesteryl ester in mouse lysosomal acid lipase.人源和鼠源溶酶体酸性脂肪酶底物特异性的差异:鼠源溶酶体酸性脂肪酶对胆固醇酯的亲和力较低。
Biochim Biophys Acta. 2000 Sep 27;1487(2-3):155-62. doi: 10.1016/s1388-1981(00)00091-3.
6
Cysteine residues in human lysosomal acid lipase are involved in selective cholesteryl esterase activity.人类溶酶体酸性脂肪酶中的半胱氨酸残基参与选择性胆固醇酯酶活性。
Biochem J. 1997 Aug 15;326 ( Pt 1)(Pt 1):265-9. doi: 10.1042/bj3260265.
7
Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.遗传和生化证据表明,CESD和沃尔曼病可通过残余溶酶体酸性脂肪酶活性加以区分。
Genomics. 1996 Apr 1;33(1):85-93. doi: 10.1006/geno.1996.0162.
8
Human lysosomal acid lipase/cholesteryl ester hydrolase and human gastric lipase: site-directed mutagenesis of Cys227 and Cys236 results in substrate-dependent reduction of enzymatic activity.人溶酶体酸性脂肪酶/胆固醇酯水解酶与人胃脂肪酶:半胱氨酸227和半胱氨酸236的定点诱变导致酶活性的底物依赖性降低。
J Lipid Res. 1997 Sep;38(9):1896-905.
9
New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease.新的溶酶体酸性脂肪酶基因突变解释了沃尔曼病和胆固醇酯贮积病的表型。
J Lipid Res. 1998 Jul;39(7):1382-8.
10
Systematic mutagenesis of potential glycosylation sites of lysosomal acid lipase.溶酶体酸性脂肪酶潜在糖基化位点的系统性诱变
J Biochem. 2005 Mar;137(3):387-94. doi: 10.1093/jb/mvi043.

引用本文的文献

1
Cysteine residues in human lysosomal acid lipase are involved in selective cholesteryl esterase activity.人类溶酶体酸性脂肪酶中的半胱氨酸残基参与选择性胆固醇酯酶活性。
Biochem J. 1997 Aug 15;326 ( Pt 1)(Pt 1):265-9. doi: 10.1042/bj3260265.